Cardiology

Lessons from major heart trial need implementation

A NewYork-Presbyterian Hospital/Weill Cornell Medical Center review of almost 500,000 cardiac cases nationally shows that the clinically indicated medical therapy reported in a widely publicized study was lost in translation ...

Medical research

New potential atherosclerosis risk marker discovered

How your carotid artery moves can reveal your risk of a future heart attack, and it is now possible to study this vessel aspect in more detail thanks to a new technique which could eventually be used to identify patients ...

Cardiology

Evinacumab cuts cholesterol levels by half in patients with HoFH

The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol to near-normal levels among patients with a rare cholesterol disorder, meeting the primary endpoint in the first randomized placebo-controlled ...

Cardiology

Rivaroxaban reduces risk in symptomatic PAD post-intervention

People with symptomatic peripheral artery disease (PAD) who took the blood thinner rivaroxaban with aspirin after undergoing a procedure to treat blocked arteries in the leg (lower extremity revascularization) had a 15% reduction ...

Cardiology

New study shows therapy for psoriasis can reduce heart plaque

Late-breaking clinical science shows common therapy options for psoriasis (PSO)-a chronic inflammatory skin disease-can help reduce coronary plaque. The authors found that not only do the treatments reduce the volume of the ...

Psychology & Psychiatry

Are antidepressants safe in patients with coronary heart disease?

An investigation published in the current issue of Psychotherapy and Psychosomatics explores the cardiac events that may occur with the use of antidepressant drugs in coronary artery disease. The aim of this study was assessing ...

page 12 from 18